EF B‐cell activation was previously described as an the major contributors to inflammatory response27, 53, 54 and associated with autoantibodies production, IL‐6, CRP and autoantibody serum concentrations in patients with COVID‐19 (Figure S2c).23, 24, 33. Here, IL6 is linked to COVID-19.